Abstract
The aim of this article was that high-density lipoprotein cholesterol (HDL-C) reduces blood vessel injury through its antioxidant and anti-inflammatory functions. However, the effect of HDL-C on blood pressure may be controversial. Therefore, the aim of this study was to address whether HDL-C level is associated with blood pressure, and we examined cross-sectional data from community-dwelling persons. A total of 859 men [58 ± 15 (mean ± standard deviation); 20–89 (range) (years) and 1,169 women (61 ± 13; 19–88 years)] participants not on medication for hypertension were recruited from a single community at the time of their annual health examination. We examined the relationship between cardiovascular risk factors and blood pressure status. Multiple linear regression analysis using systolic blood pressure (SBP) and diastolic blood pressure (DBP) as an objective variable showed that HDL-C was significantly and independently associated with both SBP (β = 0.138), and DBP (β = 0.144). Compared to normotensive participants with the lowest quartile of HDL-C, multivariate-adjusted odds ratio (OR) for pre-hypertension was 1.72 (1.22–2.45) for the second quartile, 1.51 (1.07–2.15) for the third quartile, and 1.52 (1.04–2.22) for the highest quartile. Moreover, compared with normotensive participants with the lowest quartile, the multivariate-adjusted ORs for hypertension were 2.37 (1.63–3.45), 2.24 (1.54–3.28), 3.15 (2.10–4.74), respectively. There were no interactions between the two groups stratified by gender, age, BMI, drinking status, TG, FPG, and medication. Therefore, we concluded that HDL-C levels were positively associated with blood pressure in Japanese dwelling-community persons.
Similar content being viewed by others
Abbreviations
- T-C:
-
Total cholesterol
- TG:
-
Triglycerides
- HDL-C:
-
High-density lipoprotein cholesterol
- LDL-C:
-
Low-density lipoprotein cholesterol
References
P.P. Toth, The “good cholesterol” high-density lipoprotein. Circulation 111, e89–e91 (2005)
S.E. Nissen, J.C. Tardif, S.J. Nicholls, J.H. Revkin, C.L. Shear, W.T. Duggan, W. Ruzyllo, W.B. Bachinsky, G.P. Lasala, E.M. Tuzcu, ILLUSTRATE investigators: effect of torcetrapib on the progression of coronary atherosclerosis. N. Engl. J. Med. 356, 1304–1316 (2007)
K. Shiwaku, A. Nogi, K. Kitajima, E. Anuurad, B. Enkhmaa, M. Yamasaki, J.M. Kim, I.S. Kim, S.K. Lee, T. Oyunsuren, Y. Yamane, Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J. Occup. Health 47, 126–135 (2005)
G.M. Reaven, Role of insulin resistance in human disease. Diabetes 37, 1595–1607 (1988)
N.M. Kaplan, The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch. Intern. Med. 149, 1514–1520 (1989)
R.A. DeFronzo, E. Ferrannini, Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14, 173–194 (1991)
R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)
P.S. Tsai, T.L. Ke, C.J. Huang, J.C. Tsai, P.L. Chen, S.Y. Wang, Y.K. Shyu, Prevalence and determinants of pre-hypertension status in the Taiwanese general population. J. Hypertens. 23, 1355–1360 (2005)
R. Kawamoto, K. Kohara, Y. Tabara, M. Abe, T. Kusunoki, T. Miki, Insulin resistance and prevalence of pre-hypertension and hypertension among community-dwelling persons. J. Atheroscler. Thromb. 17, 148–155 (2010)
P.J. Chowienczyk, G.F. Watts, J.R. Cockcroft, J.M. Ritter, Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340, 1430–1432 (1992)
P.R. Casino, C.M. Kilcoyne, A.A. Quyyumi, J.M. Hoeg, J.A. Panza, The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88, 2541–2547 (1993)
E. Oda, R. Kawai, High-density lipoprotein cholesterol is positively associated with hypertension in apparently healthy Japanese men and women. Br. J. Biomed. Sci. 68, 29–33 (2011)
R. Kawamoto, Y. Tabara, K. Kohara, T. Miki, T. Kusunoki, S. Takayama, M. Abe,T. Katho, N. Ohtsuka, Usefulness of combining serum uric acid and high-sensitivity C-reactive protein for risk stratification of patients with metabolic syndrome in community-dwelling women. Endocrine 41, in press (2012)
A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr, D.W. Jones, B.J. Materson, S. Oparil, J.T. Wright Jr, E.J. Roccella, Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. National heart, lung, and blood institute; national high blood pressure education program coordinating committee: the seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42, 1206–1252 (2003)
W.T. Friedewald, R.I. Levy, D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502 (1972)
E. Imai, M. Horio, T. Watanabe, K. Iseki, K. Yamagata, S. Hara, N. Ura, Y. Kiyohara, T. Moriyama, Y. Ando, S. Fujimoto, T. Konta, H. Yokoyama, H. Makino, A. Hishida, S. Matsuo, Prevalence of chronic kidney disease in the Japanese general population. Clin. Exp. Nephrol. 13, 621–630 (2009)
Emerging Risk Factors Collaboration, E. Di Angelantonio, N. Sarwar, P. Perry, S. Kaptoge, K.K. Ray, A. Thompson, A.M. Wood, S. Lewington, N. Sattar, C.J. Packard, R. Collins, S.G. Thompson, J. Danesh, Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302, 1993–2000 (2009)
R.O. Halperin, H.D. Sesso, J. Ma, J.E. Buring, M.J. Stampfer, J.M. Gaziano, Dyslipidemia and the risk of incident hypertension in men. Hypertension 47, 45–50 (2006)
H.D. Sesso, J.E. Buring, M.J. Chown, P.M. Ridker, J.M. Gaziano, A prospective study of plasma lipid levels and hypertension in women. Arch. Intern. Med. 165, 2420–2427 (2005)
N.P. Paynter, H.D. Sesso, D. Conen, J.D. Otvos, S. Mora, Lipoprotein subclass abnormalities and incident hypertension in initially healthy women. Clin. Chem. 57, 1178–1187 (2011)
H. Becher, The concept of residual confounding in regression models and some applications. Stat. Med. 11, 1747–1758 (1992)
M. Vergeer, A.G. Holleboom, J.J.P. Kastelein, J.A. Kuivenhoven, The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis? Lipid Res. 51, 2058–2073 (2010)
H. Pearson, When good cholesterol turns bad. Nature 444, 794–795 (2006)
H. Drexel, F.W. Amann, K. Rentsch, C. Neuenschwander, A. Luethy, S.I. Khan, F. Follath, Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am. J. Cardiol. 70, 436–440 (1992)
M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, A.M. Fogelman, A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids. J. Lipid Res. 42, 1308–1317 (2001)
W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, A. Kontush, Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function. Arterioscler. Thromb. Vasc. Biol. 29, 870–876 (2009)
B.J. Ansell, G.C. Fonarow, A.M. Fogelman, High-density lipoprotein: is it always atheroprotective? Curr. Atheroscler. Rep. 8, 405–411 (2006)
M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, S. Hama, G. Hough, E. Bachini, V.R. Grijalva, A.C. Wagner, Z. Shaposhnik, A.M. Fogelman, The double jeopardy of HDL. Ann. Med. 37, 173–178 (2005)
E.R. De Oliveira E Silva, D. Foster, M. McGee Harper, C.E. Seidman, J.D. Smith, J.L. Breslow, E.A. Brinton, Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II. Circulation 102, 2347–2352 (2000)
F.D. Fuchs, L.E. Chambless, P.K. Whelton, F.J. Nieto, G. Heiss, Alcohol consumption and the incidence of hypertension: the atherosclerosis risk in communities study. Hypertension 37, 1242–1250 (2001)
H.D. Sesso, N.R. Cook, J.E. Buring, J.E. Manson, J.M. Gaziano, Alcohol consumption and the risk of hypertension in women and men. Hypertension 51, 1080–1087 (2008)
Acknowledgment
This study was supported in part by a grant-in-aid from the Foundation for Development of Community (2011).
Competing interests
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Additional information
Author’s contributions
RK, YT, and KK participated in the design of the study, performed the statistical analysis and drafted the manuscript. TK contributed to the acquisition of data and its interpretation. MA contributed to the conception and design of the statistical analysis. TM conceived of the study, participated in its design, coordination and helped to draft the manuscript. All authors read and approved the manuscript.
Rights and permissions
About this article
Cite this article
Kawamoto, R., Tabara, Y., Kohara, K. et al. Increased high-density lipoprotein cholesterol is associated with a high prevalence of pre-hypertension and hypertension in community-dwelling persons. Endocrine 42, 321–328 (2012). https://doi.org/10.1007/s12020-012-9625-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-012-9625-z